Page last updated: 2024-12-07

cycloleucalenol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

cycloleucalenol: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID101690
CHEMBL ID225634
CHEBI ID16653
SCHEMBL ID569261
MeSH IDM0050233

Synonyms (27)

Synonym
CHEBI:16653 ,
cycloleucalenol
3beta,4alpha,5alpha-4,14-dimethyl-9,19-cycloergost-24(28)-en-3-ol
4alpha,14-dimethyl-9beta,19-cyclo-5alpha-ergost-24(28)-en-3beta-ol
469-39-6
cycloeucalenol ,
C02141
296B38AD-04D4-47A1-8AC8-D97BD9BE6224
CHEMBL225634
LMST01100011
unii-7of1q9ue9r
9,19-cycloergost-24(28)-en-3-ol, 4,14-dimethyl-, (3beta,4alpha,5alpha)-
7of1q9ue9r ,
3.beta.-cycloeucalenol
4.alpha.,14.alpha.-dimethyl-9,19-cyclopropane-24(28)-methylenecholestan-3.beta.-ol
9,19-cycloergost-24(28)-en-3-ol, 4,14-dimethyl-, (3.beta.,4.alpha.,5.alpha.)-
cycloartanol, 4.beta.-demethyl-24-methylene
9,19-cyclo-5.alpha.,9.beta.-ergost-24(28)-en-3.beta.-ol, 4.alpha.,14-dimethyl-
SCHEMBL569261
FS-9905
(1s,3r,6s,7s,8s,11s,12s,15r,16r)-7,12,16-trimethyl-15-[(2r)-6-methyl-5-methylideneheptan-2-yl]pentacyclo[9.7.0.01,3.03,8.012,16]octadecan-6-ol
Q27102014
4,14-dimethyl-9,19-cycloergost-24(28)-en-3-ol
DTXSID70963693
9,19-cyclo-5,9-ergost-24(28)-en-3-ol, 4,14-dimethyl-
GLXC-17775
AKOS040761557
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
phytosterolsSterols similar to cholesterol which occur in plants and vary only in carbon side chains and/or presence or absence of a double bond.
3beta-sterolA sterol in which the hydroxy group at position 3 has beta- configuration.
pentacyclic triterpenoid
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
phytosterol biosynthesis (plants)1531
Sterol biosynthesis525

Bioassays (7)

Assay IDTitleYearJournalArticle
AID288766Scavenging activity against NO generation in human Chang liver cells assessed as inhibition of NOR1-activation at 350 nM relative to NOR12007Journal of natural products, Jun, Volume: 70, Issue:6
Cancer chemopreventive effects of cycloartane-type and related triterpenoids in in vitro and in vivo models.
AID288762Inhibition of TPA-induced Epstein-Barr virus early antigen activation assessed as EBV-EA induction in Raji cells at 3.2 nM after 48 hrs relative to TPA2007Journal of natural products, Jun, Volume: 70, Issue:6
Cancer chemopreventive effects of cycloartane-type and related triterpenoids in in vitro and in vivo models.
AID288764Inhibition of TPA-induced Epstein-Barr virus early antigen activation in Raji cells after 48 hrs2007Journal of natural products, Jun, Volume: 70, Issue:6
Cancer chemopreventive effects of cycloartane-type and related triterpenoids in in vitro and in vivo models.
AID288765Cell viability of Raji cells at 320 nM2007Journal of natural products, Jun, Volume: 70, Issue:6
Cancer chemopreventive effects of cycloartane-type and related triterpenoids in in vitro and in vivo models.
AID288763Inhibition of TPA-induced Epstein-Barr virus early antigen activation assessed as EBV-EA induction in Raji cells at 0.32 nM after 48 hrs relative to TPA2007Journal of natural products, Jun, Volume: 70, Issue:6
Cancer chemopreventive effects of cycloartane-type and related triterpenoids in in vitro and in vivo models.
AID288760Inhibition of TPA-induced Epstein-Barr virus early antigen activation assessed as EBV-EA induction in Raji cells at 320 nM after 48 hrs relative to TPA2007Journal of natural products, Jun, Volume: 70, Issue:6
Cancer chemopreventive effects of cycloartane-type and related triterpenoids in in vitro and in vivo models.
AID288761Inhibition of TPA-induced Epstein-Barr virus early antigen activation assessed as EBV-EA induction in Raji cells at 32 nM after 48 hrs relative to TPA2007Journal of natural products, Jun, Volume: 70, Issue:6
Cancer chemopreventive effects of cycloartane-type and related triterpenoids in in vitro and in vivo models.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (9.09)18.7374
1990's0 (0.00)18.2507
2000's6 (54.55)29.6817
2010's4 (36.36)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]